Publication:
Intersite validations of the pixel-wise method for liver r2* analysis in transfusion-dependent thalassemia patients: A more accessible and affordable diagnostic technology

dc.contributor.authorPairash Saiviroonpornen_US
dc.contributor.authorVip Viprakasiten_US
dc.contributor.authorKleebsabai Sanpakiten_US
dc.contributor.authorJohn C. Wooden_US
dc.contributor.authorRungroj Krittayaphongen_US
dc.contributor.otherDepartment of Radiologyen_US
dc.contributor.otherKeck School of Medicine of USCen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-06-11T05:20:16Z
dc.date.available2018-06-11T05:20:16Z
dc.date.issued2012-01-01en_US
dc.description.abstractBACKGROUND AND OBJECTIVES: MRI-R2* has been accepted as a clinical tool for monitoring iron overload in thalassemia patients, especially for monitoring liver iron concentration (LIC). The most optimal and practical method of analysis however, is still open to further investigations. Our objective was to investigate intra and intersite observer variability of the pixel-wise method for liver R2* analysis in thalassemia patients using a monoexponential with a constant offset model. Patients and Methods: We performed 88 liver R2* measurements on 72 thalassemia major patients. A single breath-hold multi-echo gradient-echo sequence was acquired and analyzed at both the reference (REF) and local (LOC) sites. The analysis defined the region of interest in the whole liver parenchyma, excluding the great vessels, and were reported as median values. Results: The R2* values from the REF and LOC were statistically comparable for all comparisons. The intrasite and intersite observer variation were 0.75% (less than 0.9%) and 2.5%, respectively, both of which are comparable to previous reports, but substantially lower than conventional region-based approaches. Conclusion: The low variation of the R2* also yielded excellent variation in the tabulated hepatic iron content. However, caution is required when comparing the results to different implementation methods and appropriate evaluation and validation of methodology for any new scan site is essential before its clinical use.en_US
dc.identifier.citationHematology/ Oncology and Stem Cell Therapy. Vol.5, No.2 (2012), 91-95en_US
dc.identifier.doi10.5144/1658-3876.2012.91en_US
dc.identifier.issn16583876en_US
dc.identifier.other2-s2.0-84866890626en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/15107
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84866890626&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleIntersite validations of the pixel-wise method for liver r2* analysis in transfusion-dependent thalassemia patients: A more accessible and affordable diagnostic technologyen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84866890626&origin=inwarden_US

Files

Collections